RESINCALCIO

Treatment and prevention of hyperkalemia. RESINCALCIO® powder for oral suspension is supplied : 400 g multidose polyethylene bottles and capacity, equipped with 5 g measuring spoon. 15 g unidose envelopes of paper / aluminum / polyethy. Each 100 g of oral suspension powder contains 99.75 g of calcium polystyrene sulfonate. Contains vanilla aroma, no added sugars.

RESINSODIO

RESINSODIO® powder for oral suspension is indicated for the treatment and prevention of hyperkalemia.

Surfactante B Richet

Intratracheal suspension used in RDS ( Respiratoryy distress syndrome)

Temozolomide Accord 100mg

Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumours: - adults with newly diagnosed specific form of brain tumour (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). - children 3 years and older and adult patients with specific forms of brain tumour (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Temozolomide Accord 20mg

Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumours: - adults with newly diagnosed specific form of brain tumour (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). - children 3 years and older and adult patients with specific forms of brain tumour (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Temozolomide Accord 250mg

Temozolomide is an anti-cancer medicine. Temozolomide Accord capsules are taken to treat specific forms of brain tumours: - adults with newly diagnosed specific form of brain tumour (glioblastoma multiforme). Temozolomide is first used together with radiotherapy (concomitant phase of treatment) and after that alone (monotherapy phase of treatment). - children 3 years and older and adult patients with specific forms of brain tumour (e.g. glioblastoma multiforme or anaplastic. astrocytoma) that has returned or where the cancer has spread after standard therapy.

Wilate 500

Wilate, produced from the plasma of human donors, is presented as a powder and solvent for solution for injection containing nominally 500 IU/1000 IU human von Willebrand factor (VWF) and human coagulation factor VIII (FVIII) per vial.

ZOLEDRONIC ACID 4mg/5ml SOLN, 1's

The active substance in Zoledronic Acid Accord is zoledronic acid, which belongs to a group of substances called bisphosphonates. Zoledronic acid works by attaching itself to the bone and slowing down the rate of bone change. It is used: • To prevent bone complications, e.g. fractures, in adult patients with bone metastases (spread of cancer from primary site to the bone). • To reduce the amount of calcium in the blood in adult patients where it is too high due to the presence of a tumour. Tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased. This condition is known as tumour-induced hypercalcaemia (TIH).